AR

Ajinkya Ranade

Director Additional Director DIN 07722213
DIN 07722213 First appointment Apr 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Ajinkya Ranade

Data last updated:

Ajinkya Ranade was an Additional Director at Cloverleaf Ecom Private Limited (2017) and Director at Dr Globe Private Limited (from 2017). The companies operate in Pharma.

DIN 07722213
Primary Designation Additional Director
Industry Pharma
First Appointment 11 Apr 2017
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cloverleaf Ecom Private Limited U93090MH2015PTC266953
Additional Director13 Apr 20172015₹6.26 Cr (FY 2024)Active
Dr Globe Private Limited U74999MH2017PTC293726
Director11 Apr 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dr Globe Private Limited
Cloverleaf Ecom Private Limited
Premium access

Shareholding and investment profile for Ajinkya Ranade

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajinkya Ranade

Ajinkya Ranade was first appointed on 11 Apr 2017 as Director at Dr Globe Private Limited.

Ajinkya Ranade held 2 earlier board appointments: Cloverleaf Ecom Private Limited (Additional Director, 13 Apr 2017 to 04 Jul 2017); Dr Globe Private Limited (Director, from 11 Apr 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available